Maze Therapeutics, Inc. Financial Overview
Maze Therapeutics, Inc.'s market cap is currently $2.01B. The company's EPS TTM is $-0.66; its P/E ratio is -18.50; Maze Therapeutics, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
